UPDATE: BioMerieux Logs 4 Percent Organic Growth in 1H 2014; BioFire Helps Drive Molecular Bio Gains | GenomeWeb

This story has been updated from a version originally published on July 17 to incorporate additional figures from BioMérieux's first-half financial results, which were released today.

NEW YORK (GenomeWeb) — BioMérieux has reported 4 percent organic revenue growth for the first half of 2014 driven in part by a 4 percent increase in clinical revenues and a nearly 10 percent spike in clinical molecular biology sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.